Symposium recording "Thiamidol, an Innovation in Hyperpigmentation: Therapeutic Benefits"

Our patented active ingredient Thiamidol, a tyrosinase inhibitor, is the most targeted dermocosmetic solution against hyperpigmentation. With a faculty of expert Dermatologists, our symposium highlighted Eucerin’s fight against acne stigmatization, the latest European real-world evidence in both even-skin and post-inflammatory hyperpigmentation as well as cosmetic benefits of Thiamidol in skin of color and laser treatments.

Symposium recording "Global burden of skin cancer - Is there glory in prevention"

The symposium on sun protection highlighted the unparalleled benefits of SPF 100 over SPF 50, revealing its specialized advantages for patients with aktinic keratosis and in preventing its development. Eucerin´s medical device Actinic Control offers an SPF100 in a superior galenic. The presented in vitro data demonstrated that Actinic Control provided superior protection over SPF 50 against UV stress-induced inflammation and cell death, making it an exceptional choice for those at risk of developing AK & NMSCs.

Our speakers

ANNE-CHRISTIN WOTRHMANN

GERMANY International Medical Manager at Beiersdorf

DR CLAAS ULRICH

GERMANY Head of the Skin Tumor Center (HTCC) at Charité Berlin

PROF THIERRY PASSERON

FRANCE University of Nice Sophia Antipolis

DR MARISA TAYLOR

UK Consultant Dermatologist at Epsom and St Helier University Hospitals NHS Trust

DR LUDGER KOLBE

GERMANY Chief Scientist for Photobiology at Beiersdorf AG

DR WOLFGANG PHILIPP-DORMSTON

GERMANY Head of Department of Dermatology, Allergology and Dermatologic Surgery, Hospital KLINIK LINKS VOM RHEIN

Make a Difference With Social Mission Program

Working with local partners in multiple countries worldwide, we've started projects that include individual coaching, group learning experiences, and awareness raising to help those who suffer from social exclusion and stigmatisation due to their skin concerns.
Link to social mission page